Last reviewed · How we verify
NCT05803564
Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm.
NA trial testing Thoracoabdominal aortic stent system in Thoracoabdominal; Aortic, Aneurysm, Dissecting in 46 participants. Currently enrolling.
1 November 2026
Quick facts
| Lead sponsor | Lifetech Scientific (Shenzhen) Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 46 |
| Start date | 1 October 2021 |
| Primary completion | 1 November 2026 |
| Estimated completion | 1 October 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- Thoracoabdominal aortic stent system
Conditions studied
- Thoracoabdominal; Aortic, Aneurysm, Dissecting — all drugs for Thoracoabdominal; Aortic, Aneurysm, Dissecting →
Sponsor
Lifetech Scientific (Shenzhen) Co., Ltd. — full company profile →
Who can join
Adults 18 to 80, any sex, with Thoracoabdominal; Aortic, Aneurysm, Dissecting. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A First in man study to evaluate the safety and efficacy of thoracoabdominal aortic stent system for endovascular treatment of thoracoabdominal aortic dissecting aneurysm.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05803564
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Thoracoabdominal aortic stent system
Trials testing the same drug.
- NCT04731636 — Guo's Visceral Arteries Reconstruction: First in Man Study · NA · completed
Other recruiting trials for Thoracoabdominal; Aortic, Aneurysm, Dissecting
Currently open trials in the same condition.
- NCT04524247 — Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies · NA · recruiting
Other Lifetech Scientific (Shenzhen) Co., Ltd. trials
Trials by the same sponsor.
- NCT07385599 — FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients · NA · active not recruiting
- NCT06915545 — Study on the Aortic Arch Single Branch Stent Graft System · NA · recruiting
- NCT06849635 — Cera™ ASD Occluder Post-Market Clinical Follow-Up Study · recruiting
- NCT06700174 — Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study · recruiting
- NCT06520774 — Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05803564 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lifetech Scientific (Shenzhen) Co., Ltd.
- Last refreshed: 22 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05803564.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing